ANZBMS 2026
Chairs: Christopher Hernandez & Kaitlyn Flynn
A decade of discovery: epigenetic control of mesenchymal stem cell fate links bone ageing, osteoporosis, and metabolic disease (#42)
2:00 PM
ACC1-mediated mitochondrial fatty acid synthesis (mtFAS) governs osteoclast activation and bone loss (#43)
2:30 PM
EphrinB2:EphB4 signalling limits lysosome formation in osteoblasts: in its absence lysosomes and collagen are released and promote mineralisation (#44)
2:42 PM
Endogenous glucocorticoids induce neurogenic heterotopic ossification via mesenchymal and myeloid cells (#45)
2:54 PM
SOST-targeted Antisense Oligonucleotide Mimics Splicing Mutation in Sclerosteosis to Enhance Osteogenesis In Vitro (#46)
3:06 PM
Hyperbranched Polyglycerol–Coated Titanium Implants Reduce In Vivo Bacterial Burden Without Compromising Osseointegration (#47)
3:18 PM